KindlyMD (NASDAQ:NAKA) Announces Quarterly Earnings Results

Key Points

• KindlyMD (NASDAQ: NAKA) reported a negative earnings per share of ($0.34) for the recent quarter, with a negative return on equity of 146.26% and a negative net margin of 177.01%.
• The stock price of KindlyMD fell by $0.24 on Tuesday, bringing it to $7.34, with a trading volume significantly lower than its average.
• Founded in 2019, KindlyMD is dedicated to holistic pain management and aims to reduce opioid use in patients with chronic pain.

KindlyMD (NASDAQ:NAKA - ) posted its earnings results on Tuesday. The company reported ($0.34) earnings per share for the quarter, Zacks reports. KindlyMD had a negative return on equity of 146.26% and a negative net margin of 177.01%.

KindlyMD Stock Performance

NAKA traded down $0.24 during mid-day trading on Tuesday, hitting $7.34. The stock had a trading volume of 222,320 shares, compared to its average volume of 3,219,943. KindlyMD has a 1-year low of $0.65 and a 1-year high of $34.77. The firm has a market cap of $53.62 million, a PE ratio of -9.53 and a beta of 34.44.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.